Evaluating the influence of mechanical stress on anticancer treatments through a multiphase porous media model.
暂无分享,去创建一个
[1] R. Penta,et al. The role of the microvascular network structure on diffusion and consumption of anticancer drugs , 2017, International journal for numerical methods in biomedical engineering.
[2] John Lowengrub,et al. An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity. , 2016, Nanomedicine.
[3] Luigi Preziosi,et al. Predicting the growth of glioblastoma multiforme spheroids using a multiphase porous media model , 2016, Biomechanics and Modeling in Mechanobiology.
[4] F. Michor,et al. The mathematics of cancer: integrating quantitative models , 2015, Nature Reviews Cancer.
[5] Tianlin Liu,et al. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing , 2015, PloS one.
[6] Triantafyllos Stylianopoulos,et al. Stress-mediated progression of solid tumors: effect of mechanical stress on tissue oxygenation, cancer cell proliferation, and drug delivery , 2015, Biomechanics and Modeling in Mechanobiology.
[7] Aude Michel,et al. Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure , 2015, Nature.
[8] D. Richardson,et al. Glucose modulation induces reactive oxygen species and increases P‐glycoprotein‐mediated multidrug resistance to chemotherapeutics , 2015, British journal of pharmacology.
[9] D. Ambrosi,et al. The role of the microvascular tortuosity in tumor transport phenomena. , 2015, Journal of theoretical biology.
[10] J. Joanny,et al. Compressive stress inhibits proliferation in tumor spheroids through a volume limitation. , 2014, Biophysical journal.
[11] Min Wu,et al. The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems. , 2014, Journal of theoretical biology.
[12] Martin G Pomper,et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[13] R. Jain,et al. The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.
[14] Robert J. Gillies,et al. Current Advances in Mathematical Modeling of Anti-Cancer Drug Penetration into Tumor Tissues , 2013, Front. Oncol..
[15] Mauro Ferrari,et al. On Computational Modeling in Tumor Growth , 2013, Archives of Computational Methods in Engineering.
[16] R. Jain,et al. Strategies for advancing cancer nanomedicine. , 2013, Nature materials.
[17] Heiko Rieger,et al. Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model , 2013, PloS one.
[18] X. Wang,et al. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. , 2013, Biomaterials.
[19] C. Allen,et al. Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere® , 2013, PloS one.
[20] K. Borden,et al. Mechanisms and insights into drug resistance in cancer , 2013, Front. Pharmacol..
[21] H M Byrne,et al. Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[22] Triantafyllos Stylianopoulos,et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors , 2012, Proceedings of the National Academy of Sciences.
[23] C. Giverso,et al. Modelling the compression and reorganization of cell aggregates. , 2012, Mathematical medicine and biology : a journal of the IMA.
[24] Luigi Preziosi,et al. The interplay between stress and growth in solid tumors , 2012 .
[25] Maria Vinci,et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation , 2012, BMC Biology.
[26] Victor M. Calo,et al. Mathematical modeling of coupled drug and drug-encapsulated nanoparticle transport in patient-specific coronary artery walls , 2012 .
[27] Hans G Othmer,et al. The role of the microenvironment in tumor growth and invasion. , 2011, Progress in biophysics and molecular biology.
[28] Christopher W Mount,et al. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. , 2010, Biomaterials.
[29] H. Byrne. Dissecting cancer through mathematics: from the cell to the animal model , 2010, Nature Reviews Cancer.
[30] L Preziosi,et al. An elasto-visco-plastic model of cell aggregates. , 2010, Journal of theoretical biology.
[31] Luigi Preziosi,et al. Contact inhibition of growth described using a multiphase model and an individual cell based model , 2009, Appl. Math. Lett..
[32] Mauro Ferrari,et al. Prediction of drug response in breast cancer using integrative experimental/computational modeling. , 2009, Cancer research.
[33] R. Jain,et al. Micro-Environmental Mechanical Stress Controls Tumor Spheroid Size and Morphology by Suppressing Proliferation and Inducing Apoptosis in Cancer Cells , 2009, PloS one.
[34] Valerie M. Weaver,et al. A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.
[35] S. Pun,et al. Spatio‐temporal modeling of nanoparticle delivery to multicellular tumor spheroids , 2008, Biotechnology and bioengineering.
[36] William G. Gray,et al. Essentials of Multiphase Flow and Transport in Porous Media , 2008 .
[37] Brent D Weinberg,et al. Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[38] I. Tannock,et al. Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.
[39] Ricky T. Tong,et al. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. , 2007, Cancer research.
[40] M. Chaplain,et al. Mathematical modelling of the loss of tissue compression responsiveness and its role in solid tumour development. , 2006, Mathematical medicine and biology : a journal of the IMA.
[41] D. Ma,et al. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy , 2005, Journal of Cancer Research and Clinical Oncology.
[42] J. King,et al. Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures. , 2003, Mathematical biosciences.
[43] L. Preziosi,et al. Modelling Solid Tumor Growth Using the Theory of Mixtures , 2001, Mathematical medicine and biology : a journal of the IMA.
[44] W. Mueller‐Klieser. Tumor biology and experimental therapeutics. , 2000, Critical reviews in oncology/hematology.
[45] R. Jain,et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.
[46] Robert S. Kerbel,et al. E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.
[47] G. Forgacs,et al. Viscoelastic properties of living embryonic tissues: a quantitative study. , 1998, Biophysical journal.
[48] R. Weinberg,et al. The restriction point and control of cell proliferation. , 1997, Current opinion in cell biology.
[49] F. Oesch,et al. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts , 1997, Oncogene.
[50] Paolo A. Netti,et al. Solid stress inhibits the growth of multicellular tumor spheroids , 1997, Nature Biotechnology.
[51] R. Kerbel,et al. Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.
[52] L. Hengst,et al. A cell cycle-regulated inhibitor of cyclin-dependent kinases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. V. Sotirchos,et al. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH , 1992, Journal of cellular physiology.
[54] S. V. Sotirchos,et al. Mathematical modelling of microenvironment and growth in EMT6/Ro multicellular tumour spheroids , 1992, Cell proliferation.
[55] R K Jain,et al. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.
[56] I. Tannock,et al. Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. , 1990, Journal of the National Cancer Institute.
[57] R K Jain,et al. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.
[58] J. P. Freyer,et al. Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. , 1986, British Journal of Cancer.
[59] R. Sutherland,et al. Oxygen tensions in multicell spheroids of two cell lines. , 1982, British Journal of Cancer.
[60] M. Abercrombie,et al. The surface properties of cancer cells: a review. , 1962, Cancer research.
[61] Cass T. Miller,et al. A multiphase model for three-dimensional tumor growth , 2013, New journal of physics.
[62] Jacques Prost,et al. Supplements to : Isotropic stress reduces cell proliferation in tumor spheroids , 2011 .
[63] H. Frieboes,et al. INVITED ARTICLE: Nonlinear modelling of cancer: bridging the gap between cells and tumours , 2010 .
[64] Luigi Preziosi,et al. Multiphase and Multiscale Trends in Cancer Modelling , 2009 .
[65] Juergen Friedrich,et al. Spheroid-based drug screen: considerations and practical approach , 2009, Nature Protocols.
[66] B. Schrefler,et al. The Finite Element Method in the Static and Dynamic Deformation and Consolidation of Porous Media , 1998 .
[67] James M. Roberts,et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.